NFC

NFC is a biotechnology company focused on the development of innovative therapeutic solutions for complex diseases, including cancer and infectious conditions. The company leverages advanced research and development to identify and optimize novel drug candidates, primarily in the small molecule modality. NFC aims to address significant unmet medical needs through its pipeline of early-stage programs. By collaborating with academic and industry partners, the company seeks to accelerate the translation of scientific discoveries into clinical applications. NFC is committed to improving patient outcomes through rigorous scientific inquiry and strategic drug development.